Skip to content

Modulatory Effects of Tiaoshen Guben Acupuncture in patients with moderate depression-fMRI/EEG study

Modulatory Effects of Tiaoshen Guben Acupuncture in patients with moderate depression-fMRI/EEG study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001199
Enrollment
Unknown
Registered
2025-06-17
Start date
2025-06-21
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

moderate Depression

Interventions

Sham acupuncture group:The sham Tiaoshenguben Acupuncture
Acupuncture group:Tiaoshenguben Acupuncture
Healthy control group:none

Sponsors

Bao'an District Traditional Chinese Medicine Hospital Bao'an District Shenzhen City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: For the depression patients: (1) Pregnant women; (2) Patients combined with severe primary diseases of the heart brain liver kidney and hematopoietic system; (3) Patients with acute diseases infectious diseases or malignant tumors; (4) Patients with a history of schizophrenia or other mental illnesses; (5) Patients with cognitive disorders or personality disorders; (6) Individuals with severe suicidal ideation or suicidal behavior; (7) Patients with organic brain damage (e.g. epilepsy) or other diseases involving paroxysmal brain electrical discharges; (8) Individuals who have undergone electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) within the recent 3 months; (9) Individuals with HAMD-17 score > 23; (10) Participants involved in the MRI substudy but having MRI contraindications or failing to meet quality control requirements. Healthy controls: (1) Sex age years of education comparable to the patient group; (2) HAMD-17 and Pittsburgh Sleep Quality Index (PSQI) total scores both < 7; (3) No severe mental illnesses and physical diseases; (4) Right-handed; (5) No metal implants in the body and no claustrophobia. For the healthy controls: (1) Sex age years of education comparable to the patient group;(2) HAMD-17 and Pittsburgh Sleep Quality Index (PSQI) total scores both < 7; (3) No severe mental illnesses and physical diseases; (4) Right-handed; (5) No metal implants in the body and no claustrophobia.

Exclusion criteria

Exclusion criteria: (1) Pregnant women; (2) Patients combined with severe primary diseases of the heart brain liver kidney and hematopoietic system; (3) Patients with acute diseases infectious diseases or malignant tumors; (4) Patients with a history of schizophrenia or other mental illnesses; (5) Patients with cognitive disorders or personality disorders; (6) Individuals with severe suicidal ideation or suicidal behavior; (7) Patients with organic brain damage (e.g. epilepsy) or other diseases involving paroxysmal brain electrical discharges; (8) Individuals who have undergone electroconvulsive therapy (ECT) or transcranial magnetic stimulation (TMS) within the recent 3 months; (9) Individuals with HAMD-17 score > 23; (10) Participants involved in the MRI substudy but having MRI contraindications or failing to meet quality control requirements. Healthy controls: (1) Accompanied by psychotic symptoms; (2) Females in pregnancy lactation period or with planned pregnancy; (3) Alcohol or substance abuse; (4) History of organic brain lesions and brain injury; (5) Existence of any history of mental illnesses or neurological diseases; (6) Patients combined with severe primary diseases of the heart brain liver kidney and hematopoietic system; (7) Recent suicidal behavior or obvious suicidal tendencies; (8) Participants involved in the MRI substudy but having magnetic resonance imaging (MRI) scanning contraindications or being unable to meet quality control requirements.

Design outcomes

Primary

MeasureTime frame
The reduction rate of HAMD-17;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index;Insomnia Severity Index;Hamilton Anxiety Scale;functional magnetic resonance imaging;Self-Rating Depression Scale;17-item Hamilton Depression Scale;Ruminative Response Scale;36-item Short-Form Health Survey;Electroencephalogram;Trail Making Test;

Countries

China

Contacts

Public ContactPeng Zhou

Bao'an District Traditional Chinese Medicine Hospital No. 25 Yu'an 2nd Road Bao'an District Shenzhen City Guangdong Province

zhoupeng80@gzucm.edu.cn13714077462

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026